Prothena Corp Public (PRTA) Receivables (2013 - 2023)
Prothena Corp Public's (PRTA) quarterly Receivables came in at $5.2 million in Q4 2023, little changed quarter-over-quarter from $5.2 million in Q3 2023.
Prothena Corp Public (PRTA) Receivables (2013 - 2023) Analysis & Trends
Prothena Corp Public's Receivables history runs 10 years deep, the most recent figure standing at $5.2 million for Q4 2023.
- On a quarterly basis, Receivables changed N/A year-over-year to $5.2 million in Q4 2023; TTM through Dec 2023 was $5.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $5.2 million, changed N/A from the prior year.
- Receivables held at $5.2 million in Q4 2023 per PRTA's latest filing, from $5.2 million in the prior quarter.
- Across five years, Receivables topped out at $5.2 million in Q3 2023 and bottomed at $1000.0 in Q1 2021.
- The 4-year median for Receivables is $56000.0 (2020), against an average of $869923.1.
- Across the five-year window, Receivables surged 3300.0% in 2019 and plunged 99.43% in 2021, its largest moves.
- Year by year, Receivables stood at $68000.0 in 2019, then sank by 77.94% to $15000.0 in 2020, then jumped by 426.67% to $79000.0 in 2021, then surged by 6430.38% to $5.2 million in 2023.
- Per Business Quant, the three latest PRTA Receivables figures stand at $5.2 million (Q4 2023), $5.2 million (Q3 2023), and $524000.0 (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 4.97 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 938.02 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 5.16 Mn |
| Jun 30, 2023 | 524,000.00 |
| Sep 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | 174,000.00 |
| Dec 31, 2019 | 68,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 7,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Jun 30, 2018 | 8,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 240,000.00 |
| Sep 30, 2017 | 220,000.00 |
| Jun 30, 2017 | 30.24 Mn |
| Mar 31, 2017 | 271,000.00 |